Location History:
- Daejeon, KR (2013 - 2017)
- Sejong-si, KR (2020 - 2021)
Company Filing History:
Years Active: 2013-2025
Title: Dae-Guen Choi: Innovator in Nucleic Acid Technologies
Introduction
Dae-Guen Choi is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of nucleic acid technologies, holding a total of 7 patents. His innovative work focuses on methods and apparatuses that enhance the application of nucleic acids in various medical and technological fields.
Latest Patents
One of Dae-Guen Choi's latest patents is a method for manufacturing nucleic acid film and an apparatus for injecting medicine using this film. This method involves several steps, including mixing a nucleic acid in powder form with distilled or deionized water to create a mixed solution. The solution is then stirred, applied to a mold, and dried to form a nucleic acid film. Notably, the mold features a groove that allows the resulting film to have a protrusion designed to correspond with human skin.
Another significant patent is for a transparent conductor that includes a nanostructure and its manufacturing method. This invention comprises a transparent substrate with a transparent conductive pattern formed on it. The nanostructure is integrated into the upper surface of either the substrate or the conductive pattern, enhancing the functionality of the transparent conductor.
Career Highlights
Dae-Guen Choi has worked with esteemed organizations such as the Korea Institute of Machinery & Materials and Admbioscience Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in the field of nucleic acids.
Collaborations
Throughout his career, Dae-Guen Choi has collaborated with notable colleagues, including Jun-ho Jeong and Ji Hye Lee. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation.
Conclusion
Dae-Guen Choi's work in nucleic acid technologies exemplifies the impact of innovation in the medical and technological fields. His patents reflect a commitment to advancing the application of nucleic acids, paving the way for future developments.